《 復牌公告》中國北大荒(00039.HK)擬發新股籌8,500萬元
中國北大荒(00039.HK)公佈,與投資人訂立具有法律約束力的條款書,據此投資人有條件同意認購,而公司有條件同意根據特別授權配發及發行8.5億股認購股份,認購價爲每股0.1元,總認購價爲8,500萬元,佔公司經配發及發行認購股份及計劃股份擴大後已發行股本的約11.25%。
而根據債權人計劃,將解除其對公司的債權及公司將獲完全免除計劃債權人對公司的債權,將認購事項的所得款項4,500萬元或公司根據特別授權將予配發及發行的3.78億股計劃股份,計劃債權人可選擇以股份或出售股份的所得款項的方式收取;及建議出售計劃資產的所得款項。
公司於今日在聯交所恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.